Archive for February, 2009
Saturday, February 28th, 2009
TopNews United States
Synta suspends skin-cancer trial on safety concernsReutersO: Quote, Profile, Research) suspended a late-stage trial of its experimental drug for a deadly skin cancer after an independent data monitoring committee identified safety concerns, including a greater number of deaths in patients taking the drug. …Synta shares sink on suspension of skin-cancer trial Reuters UKSynta [...]
Posted in Uncategorized | No Comments »
Saturday, February 28th, 2009
Skin Cancer – DASH/HealthyYouthProtection from ultraviolet (UV) exposure during childhood and adolescence reduces the risk for skin cancer in adulthood. Young people spend a substantial proportion of
Skin Cancer Slideshow on RxList.comSlideshow on precancerous lesions that may lead to skin cancer over time, including melanoma, basal cell carcinoma, and squamous cell carcinoma. Learn [...]
Posted in Uncategorized | No Comments »
Friday, February 27th, 2009
Skin Cancer – Symptoms, Diagnosis, Treatment of Skin Cancer – NY Times Free articles and multimedia from The NY Times, including information on symptoms, diagnosis, treatments, tests, and surgical procedures, as well as current news and interviews
Skin Cancer – Overview – oncologychannelSkin cancer is categorized as one of two general [...]
Posted in Uncategorized | No Comments »
Friday, February 27th, 2009
Dermpath Diagnostics is exclusively focused on providing exceptional dermatopathology services. Our commitment to dermatopathology is backed by an unrivaled team of over 80 board Read on
Skin Cancer Guide: Symptoms, detection, prevention, and treatment options for Basal Cell Cancer, sBCC (Superficial Basal Cell Cancer), Squamous Cell Cancer, Melanoma, and Actinic [...]
Posted in Uncategorized | No Comments »
Friday, February 27th, 2009
Results 4th quarter and full year 2008 – Trading Markets (press release)
Results 4th quarter and full year 2008Trading Markets (press release), CAMetvix – Treatment of skin cancer The Aktilite(R) CL128 lamp was approved by the FDA in June 2008. Galderma have started the preparations for marketing and sales of Metvixia(TM) (US trademark for Metvix(R)) and Aktilite [...]
Posted in Uncategorized | No Comments »
Thursday, February 26th, 2009
Types of Skin Cancer Know The Differences Between The Main Types of Skin Cancer. When it comes to skin cancer, these are the main diagnosable types — each with different symptoms Read on
Posted in Uncategorized | No Comments »
Thursday, February 26th, 2009
What to look for to help prevent the most common cancer – ABC15.com (KNXV-TV)
What to look for to help prevent the most common cancerABC15.com (KNXV-TV), AZIt seems that public knowledge is growing about Skin Cancer; however unsafe practices such as sun bathing and tanning bed usage continue to occur. It is so important to recognize that [...]
Posted in Uncategorized | No Comments »
Thursday, February 26th, 2009
Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial – Phramalive.comSAN FRANCISCO, February 25, 2009 /PRNewswire-FirstCall/ — Medivation, Inc. today announced the presentation of new efficacy and safety data from an ongoing Phase 1-2 clinical trial of the Company’s novel androgen receptor antagonist MDV3100 in
Enhanced skin cancer risk [...]
Posted in Uncategorized | No Comments »
Thursday, February 26th, 2009
Dermatopathology Services :: Dermpath DiagnosticsDermpath Diagnostics is exclusively focused on providing exceptional dermatopathology services. Our commitment to dermatopathology is backed by an unrivaled team of over 80 board
Skin Cancer * Mole Pictures * Basal Cell * Melanoma * Picture Skin Cancer Mole Pictures * Photos of Malignant Melanoma, Basal Cell [...]
Posted in Uncategorized | No Comments »
Tuesday, February 24th, 2009
Boston, MA Current research suggests that lowering cholesterol may block the growth of prostate tumors. The related report by Solomon et al, “Ezetimibe Is an Inhibitor of Tumor Angiogenesis,” appears in the March 2009 issue of The American Journal of Read on
EMERYVILLE, Calif. – Onyx Pharmaceuticals Inc. said Monday its loss [...]
Posted in Uncategorized | No Comments »